Stock analysts at B. Riley started coverage on shares of ClearPoint Neuro (NASDAQ:CLPT – Get Free Report) in a report released on Thursday, StockNewsAPI reports. The brokerage set a “buy” rating and a $10.00 price target on the stock. B. Riley’s price objective would indicate a potential upside of 31.23% from the company’s current price.
ClearPoint Neuro Price Performance
NASDAQ CLPT opened at $7.62 on Thursday. The business’s fifty day moving average price is $6.05 and its 200-day moving average price is $6.42. The stock has a market capitalization of $208.94 million, a price-to-earnings ratio of -9.07 and a beta of 1.07. ClearPoint Neuro has a 1-year low of $4.05 and a 1-year high of $7.97.
ClearPoint Neuro (NASDAQ:CLPT – Get Free Report) last posted its quarterly earnings data on Tuesday, May 7th. The company reported ($0.16) EPS for the quarter, topping the consensus estimate of ($0.19) by $0.03. The firm had revenue of $7.64 million during the quarter, compared to analyst estimates of $7.04 million. ClearPoint Neuro had a negative return on equity of 76.92% and a negative net margin of 78.84%. Equities research analysts anticipate that ClearPoint Neuro will post -0.63 EPS for the current year.
Institutional Investors Weigh In On ClearPoint Neuro
About ClearPoint Neuro
ClearPoint Neuro, Inc operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain.
Further Reading
- Five stocks we like better than ClearPoint Neuro
- How to Buy Cheap Stocks Step by Step
- Ford Stock EPS Disappoints, Shares Plummet After-Hours
- What Do S&P 500 Stocks Tell Investors About the Market?
- How Much Should You Be Investing? Try Our Calculators
- What Are Trending Stocks? Trending Stocks Explained
- Enphase Energy Stock: Growth in the Renewable Energy Transition
Receive News & Ratings for ClearPoint Neuro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ClearPoint Neuro and related companies with MarketBeat.com's FREE daily email newsletter.